Kevin Chiem

Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.

Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.

SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination.

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.

Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.

Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.

Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X.

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening.

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.